Bg pattern

TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Totylem 60 mg/0.4 mg film-coated tablets

iron/folic acid

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.

  • Keep this leaflet, you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve.

Contents of the package leaflet

  1. What is Totylem and what is it used for
  2. What you need to know before taking Totylem
  3. How to take Totylem
  4. Possible side effects
  5. Storage of Totylem
  6. Contents of the pack and other information

1. What is Totylem and what is it used for

Totylem contains iron and folic acid as active ingredients.

This medicine belongs to a group of medicines used to treat iron deficiency disorders.

Totylem is used for the prophylaxis and treatment of iron deficiency with increased folic acid needs during pregnancy, postpartum, and lactation.

Medicine indicated only in women during pregnancy, postpartum, and lactation.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Totylem

Do not take Totylem

  • if you are allergic to iron, folic acid, or any of the other components of this medicine (listed in section 6),
  • if you have iron overload,
  • if you have anemia that is not due to iron deficiency (e.g., due to vitamin B12 deficiency),
  • if you receive frequent blood transfusions.

Warnings and precautions

Consult your doctor or pharmacist before starting to take this medicine

  • If you have difficulty swallowing. It may present a risk of ulceration of the throat or esophagus (the duct that connects the mouth to the stomach) or bronchi (the main respiratory airways of the lungs) if the tablet penetrates the respiratory tract (see warning below).
  • If you accidentally choke on a tablet, contact your doctor as soon as possible. This is because there is a risk of ulcers and narrowing of the bronchi if the tablet penetrates the respiratory tract. This can cause persistent cough, bloody sputum, and/or feeling of shortness of breath, even if the choking occurred days or months before these symptoms appear. Therefore, you should be urgently evaluated to ensure that the tablet does not damage your respiratory tract.
  • If you have a gastrointestinal disease such as chronic inflammatory bowel disease, intestinal stenosis, diverticula, gastritis, gastric and intestinal ulcers.
  • If you have liver failure. Your doctor should be cautious.
  • If you have kidney failure, because your iron needs may increase. In case of severe kidney disease, iron should be administered intravenously.
  • If you are taking other iron supplements, as high doses of iron can cause poisoning, especially in children.
  • If you are taking this medicine for the treatment of iron deficiency, the cause of the deficiency should also be investigated in order to treat it.
  • If your iron deficiency is associated with an inflammatory disease, treatment with this medicine will not be effective.
  • If you have a clinically relevant folic acid deficiency, you will need a formulation with a higher dose of folic acid.
  • If you know you have a vitamin B12 deficiency.
  • Taking iron can change the color of the stool to black.
  • According to published data obtained from patients receiving iron-based treatments, the lining of your stomach and gastrointestinal tract may be pigmented, which can interfere with gastrointestinal surgery.
  • Due to the risk of mouth ulcers and tooth discoloration, the tablets should not be sucked, chewed, or kept in the mouth, but swallowed whole with a large glass of water. If you cannot follow these instructions or have difficulty swallowing, contact your doctor.

Children and adolescents

This medicine should not be administered to children or adolescents. It is indicated exclusively in women during pregnancy, postpartum, and lactation.

Other medicines and Totylem

Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.

Some medicines cannot be used at the same time as Totylem, while others require some precautions (specific dose adjustments or changes in the time of intake), for example:

  • injectable medicines containing iron,
  • a medicine for the treatment of urinary tract infection stones (acetohydroxamic acid),
  • certain antibiotics (tetracycline antibiotics, fluoroquinolones, chloramphenicol),
  • medicines for the treatment of bone fragility (bisphosphonates, strontium),
  • medicine for the treatment of joint diseases (penicillamine),
  • medicines for the treatment of thyroid disease (e.g., levothyroxine),
  • medicines for the treatment of Parkinson's disease (entacapone, carbidopa, levodopa),
  • medicines for the treatment of HIV (integrase inhibitors),
  • trientine (a medicine used for Wilson's disease),
  • methyldopa (a medicine used for arterial hypertension),
  • zinc and calcium,
  • medicines for the treatment of stomach acidity: acid neutralizers, proton pump inhibitors, activated carbon, or antacids (aluminum, calcium, and magnesium salts),
  • medicines to eliminate or reduce the frequency of epileptic seizures, such as carbamazepine, phenobarbital, primidone, phenytoin, fosphenytoin, pheneturide,
  • an antifolate antagonist such as methotrexate or sulfasalazine,
  • 5-fluorouracil or other fluoropyrimidines used for cancer treatment,
  • a medicine for the treatment of high cholesterol (cholestyramine).

Totylem with food and drinks

Concomitant consumption of vegetables, dairy products, tea, coffee, red wine, eggs, or whole grains limits iron absorption. The administration of iron salts should be spaced from these foods by more than 2 hours (if possible).

Pregnancy and lactation

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

This medicine can be taken during and after pregnancy under normal use conditions.

Women during lactation can take this medicine.

Driving and using machines

It is unlikely that the use of this medicine will cause effects on the ability to drive or operate machines.

Totylem contains lactose and sodium.

This medicine contains lactose. Patients with hereditary galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e., it is essentially "sodium-free".

3. How to take Totylem

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist. Consult your doctor or pharmacist if you are not sure.

Women during pregnancy, postpartum, and lactation

The recommended dose for prophylaxis and treatment of iron deficiency with increased folic acid needs is 1 tablet per day, i.e., 60 mg of iron and 0.4 mg of folic acid. The recommended treatment duration is as follows:

  • Pregnant women: throughout pregnancy,
  • Women after childbirth: 6 to 12 weeks after childbirth.

Swallow the tablet whole with a glass of water. Do not suck, chew, or keep the tablet in your mouth.

Take the tablet preferably before a meal; some foods may limit iron absorption (see above the section "Totylem with food and drinks"). The intake time can be modified if necessary. The tablet can be taken with food in case of gastrointestinal intolerance.

If you take more Totylem than you should

Taking large amounts of iron can cause poisoning, especially in small children (where it can be fatal).

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.

If you take large amounts of iron, you may experience the following effects:

Severe gastrointestinal irritation, abdominal pain, vomiting (with or without blood), diarrhea often with blood, decreased blood pressure, increased respiratory and heart rate, convulsions, and kidney and liver failure.

In very high doses, folic acid can cause the following side effects: gastrointestinal disorders, mental disorders, and sleep disorders.

Consult your doctor or the nearest emergency service immediately to receive appropriate treatment.

In case of ingestion by small children, the risk of poisoning is higher and emergency treatment should be started immediately.

If you forget to take Totylem

Do not take a double dose to make up for a forgotten dose.

If you stop taking Totylem

This is not applicable.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following effects may occur, classified in decreasing order of frequency:

Frequent (may affect up to 1 in 10 patients):

  • constipation,
  • diarrhea,
  • abdominal distension,
  • abdominal pain,
  • nausea,
  • heartburn,
  • vomiting,
  • black stools (usual color).

Frequency not known (cannot be estimated from the available data):

  • allergic reaction (hypersensitivity),
  • severe allergic reaction, which can be life-threatening, including respiratory difficulties, swelling of lips, throat, and tongue, and hypotension that requires emergency treatment (anaphylactic reaction),
  • skin rash, itching (pruritus), urticaria, allergic skin reaction with skin irritation and red spots on the skin (allergic dermatitis),
  • sudden swelling of lips, cheeks, eyelids, tongue, palate, pharynx, or larynx (angioedema),
  • gastrointestinal irritation,
  • acute stomach inflammation (gastritis),
  • ulceration of the mouth and throat* (pharyngeal ulceration),
  • injury to the duct that connects the mouth to the stomach (esophageal injury),
  • narrowing of the airways (bronchial stenosis),
  • pulmonary necrosis (death of cells in the lungs),
  • ulceration of the mouth (in case of incorrect use, when tablets are chewed, sucked, or kept in the mouth),
  • brown or black spots on the teeth, reversible when treatment is discontinued (in case of incorrect use, when tablets are chewed, sucked, or kept in the mouth),
  • staining of the lining of the stomach and gastrointestinal tract (pseudomelanosis gastrointestinal).
  • Patients with difficulty swallowing also may be at risk of ulceration of the throat or esophagus (the duct that connects the mouth to the stomach) or bronchi (the main respiratory airways of the lungs), if the tablet penetrates the respiratory tract.

Reporting of side effects

If you experience any side effect, consult your doctor or pharmacist, even if it is not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Totylem

Keep this medicine out of the sight and reach of children.

Store in the original package to protect it from light. This medicine does not require any special storage temperature.

Do not use this medicine after the expiration date stated on the carton. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and other information

Composition of Totylem

  • The active ingredients are:

Iron (as ferrous gluconate hydrate) 60,000 mg

Folic acid (as folic acid hydrate) 0.400 mg

In each film-coated tablet.

  • The other ingredients are:

Ascorbic acid, hypromellose, sodium croscarmellose, magnesium stearate, lactose monohydrate, cornstarch.

Coating: hypromellose, stearic acid, microcrystalline cellulose, titanium dioxide (E171), carmine lake (E120), aluminum potassium silicate.

Appearance of the product and contents of the pack

This medicine is presented in the form of round, pinkish-beige film-coated tablets, 12 mm in diameter and 7 mm in thickness.

Each pack contains 30 film-coated tablets.

Marketing authorization holder and manufacturer

Marketing authorization holder

Laboratoire Innotech International

22 Avenue Aristide Briand

94110 Arcueil

France

Manufacturer

Innothera Chouzy

Rue Rene Chantereau, Chouzy-Sur-Cisse

41150 Valloire-Sur-Cisse

France

This medicine is authorized in the Member States of the European Economic Area under the following names:

Germany, France, Lithuania, Estonia, Portugal, Spain, Bulgaria, Malta, Croatia, Romania, Italy, Poland: TOTYLEM

Latvia: ARPELLA

Date of the last revision of this leaflet:07/2023.

Other sources of information

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS

Discuss questions about TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS?
TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS?
The active ingredient in TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS is ferrous gluconate and folic acid. This information helps identify medicines with the same composition but different brand names.
Who manufactures TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS?
TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS is manufactured by Laboratoire Innotech International. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to TOTYLEM 60 MG/0.4 MG FILM-COATED TABLETS?
Other medicines with the same active substance (ferrous gluconate and folic acid) include FOLIFERRON 100 MG / 0.150 MG FILM-COATED TABLETS, CARBOXIMALTOSA FERRICA TEVA 50 MG/ML Injectable Dispersion and Perfusion Solution, FERACCRU 30 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media